Bruker Corp. (BRKR)
54.48
-2.06
(-3.64%)
USD |
NASDAQ |
Oct 16, 15:36
Bruker Research and Development Expense (Quarterly) : 94.30M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 94.30M |
| March 31, 2026 | 101.30M |
| December 31, 2025 | 99.60M |
| September 30, 2025 | 98.30M |
| June 30, 2025 | 100.20M |
| March 31, 2025 | 97.10M |
| December 31, 2024 | 104.40M |
| September 30, 2024 | 98.10M |
| June 30, 2024 | 92.20M |
| March 31, 2024 | 81.80M |
| December 31, 2023 | 83.40M |
| September 30, 2023 | 71.30M |
| June 30, 2023 | 71.00M |
| March 31, 2023 | 69.00M |
| December 31, 2022 | 63.50M |
| September 30, 2022 | 56.20M |
| June 30, 2022 | 59.60M |
| March 31, 2022 | 56.60M |
| December 31, 2021 | 58.10M |
| September 30, 2021 | 52.10M |
| June 30, 2021 | 55.80M |
| March 31, 2021 | 54.80M |
| December 31, 2020 | 57.10M |
| September 30, 2020 | 48.30M |
| June 30, 2020 | 44.10M |
| Date | Value |
|---|---|
| March 31, 2020 | 48.50M |
| December 31, 2019 | 46.70M |
| September 30, 2019 | 46.10M |
| June 30, 2019 | 48.50M |
| March 31, 2019 | 46.40M |
| December 31, 2018 | 44.80M |
| September 30, 2018 | 41.80M |
| June 30, 2018 | 43.60M |
| March 31, 2018 | 43.20M |
| December 31, 2017 | 43.10M |
| September 30, 2017 | 40.60M |
| June 30, 2017 | 40.30M |
| March 31, 2017 | 37.60M |
| December 31, 2016 | 38.20M |
| September 30, 2016 | 37.90M |
| June 30, 2016 | 36.80M |
| March 31, 2016 | 36.10M |
| December 31, 2015 | 36.70M |
| September 30, 2015 | 34.30M |
| June 30, 2015 | 37.50M |
| March 31, 2015 | 37.20M |
| December 31, 2014 | 41.60M |
| September 30, 2014 | 42.10M |
| June 30, 2014 | 44.50M |
| March 31, 2014 | 46.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Revvity, Inc. | 48.97M |
| Waters Corp. | 121.00M |
| Agilent Technologies, Inc. | 120.00M |
| Bio-Rad Laboratories, Inc. | 61.20M |
| Danaher Corp. | 412.00M |